Medicine Matters

There's exciting news for people exploring prescription weight management options. Foundayo™ (Orforglipron) is a newly FDA-approved oral GLP-1 medication that offers something many patients have been waiting for, a once-daily tablet instead of an injection. Foundayo...

If you've heard about Medicare's new GLP-1 Bridge Program, you're not alone. Since the program launched on July 1, 2026, many patients have been asking whether they qualify and how they can take advantage of this new opportunity. The program helps certain Medicare...

Generic medications are often less expensive than brand-name medications, but many patients wonder if they work the same way. A generic drug contains the same active ingredient as the brand-name version. It must meet FDA standards for strength, dosage form, route of...